ELANCO COMPUDOSE-G WITH TYLAN GROWTH AND FINISHING IMPLANTS FOR STEERS AND HEIFERS

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:

TYLOSIN TARTRATE; TRENBOLONE ACETATE; OESTRADIOL

Available from:

ELANCO AUSTRALASIA PTY LTD

INN (International Name):

trenbolone acetate(60mg/Im)+oestradiol(12mg/Im) + others

Pharmaceutical form:

PARENTERAL IMPLANT, DEVICE

Composition:

TYLOSIN TARTRATE ANTIBIOTIC Active 29.0 mg/Im; TRENBOLONE ACETATE STEROID-ANABOLIC Active 60.0 mg/Im; OESTRADIOL STEROID-ESTROGEN Active 12.0 mg/Im

Units in package:

100implant; 20 implant

Class:

VM - Veterinary Medicine

Manufactured by:

ELANCO ANIMAL HEALTH

Therapeutic group:

HEIFER - PASTURE FED | STEER- PASTURE FED

Therapeutic area:

NUTRITION & METABOLISM

Therapeutic indications:

PROMOTE ANIMAL GROWTH | FEED CONVERSION | FINISHING | GROWTH PROMOTION | GROWTH RATE | LIVEWEIGHT GAIN

Product summary:

Poison schedule: 4; Withholding period: Meat: Nil Milk: Do not use in heifers which are producing or may in the futur e produce milk or milk products for hum an consumption.; Host/pest details: HEIFER - PASTURE FED: [PROMOTE ANIMAL GROWTH]; STEER- PASTURE FED: [PROMOTE ANIMAL GROWTH]; For improved growth promotion in pasture fed steers and heifers. Tylan is included as a local antibacterial to reduce the incidence of abscess formation caused by tylosin sensitive organisms at the implant site.See RESTRAINTS, PRECAUTIONS, etc. on label.

Authorization status:

Stopped

Authorization date:

2023-07-01

Patient Information leaflet

                                DIRECTIONS FOR USE:
USE ONLY IN ACCORDANCE WITH THE INSTRUCTIONS ON THIS LABEL UNLESS
AUTHORISED UNDER APPROPRIATE LEGISLATION.
RESTRAINTS:
FOR USE ONLY IN STEERS AND HEIFERS. DO NOT USE IN HEIFERS WHICH ARE
PRODUCING OR MAY IN THE FUTURE PRODUCE MILK OR MILK PRODUCTS FOR HUMAN
CONSUMPTION. DO NOT USE THIS PRODUCT IN ANY OTHER SPECIES OF ANIMAL.
INSERT ONLY ONE IMPLANT PER STEER OR HEIFER.
IMPLANT ONLY BENEATH THE SKIN IN THE MIDDLE THIRD OF THE EAR. DO NOT
IMPLANT THIS PRODUCT IN ANY OTHER SITE.
INSERT ONLY ONE IMPLANT EVERY 70 DAYS.
IT IS A BREACH OF AQIS ACCREDITATION CONDITIONS TO USE THIS PRODUCT ON
HGP FREE
ACCREDITED CATTLE OR TO POSSESS THIS PRODUCT ON ANY HGP FREE
ACCREDITED
PROPERTY (EXCEPT FOR FEEDLOTS WITH FLEXIBLE ACCREDITATION). CATTLE
IMPLANTED WITH
THIS PRODUCT MUST BE INDIVIDUALLY IDENTIFIED WITH AN APPROVED EAR
PUNCH MARK.
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
Approved implantation technique is fully described in the enclosed
leaflet.
Implant complete contents of a single implant (4 pellets plus marker)
per animal.
Implant site is beneath the skin on the back side of the middle
one-third of the ear.
Use of this product is appropriate when the veterinarian determines
that there is
a risk of ear abscessation due to organisms susceptible to tylosin.
PRECAUTIONS:
Implanting cattle under 3 months of age is NOT recommended.
Implanting cattle intended for breeding is NOT recommended as they may
experience decreased fertility.
Growth responses may vary widely for nutritional or other reasons.
Improved performance may be noted only when conditions are favourable
for
good growth. Vaginal, rectal and preputial prolapse, increased bulling
activity,
high tailheads, sunken loins, ventral oedema and udder development may
occur
as side effects of treatment.
To help avoid abscess formation at the site of implant, the surface of
the ear
should be thoroughly cleaned and disinfected before implantation.
Implanting too close to the base of the ear may cause bulling. Never
sacrifice
careful, clean techn
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                Page 1 
 
 
MATERIAL SAFETY DATA SHEET 
COMPUDOSE-G 
AH0359 
Revision 1.3, 22 November 2006 
 
 
STATEMENT OF HAZARDOUS NATURE: 
The intact Compudose-G implant is not considered hazardous under
normal handling 
procedures. 
The following Statement of Hazardous Nature refers to the contents of
the implant which 
contain oestradiol and trenbolone acetate: 
"Hazardous according to criteria of Worksafe Australia" 
Toxic; Reproductive Category 1. R60 May impair fertility. R61 May
cause harm to the 
unborn child. 
Harmful; Carcinogen Category 3. R40 Possible risks of irreversible
effects. 
Harmful; Mutagen Category 3. R40 Possible risks of irreversible
effects. 
 
COMPANY NAME AND ADDRESS: 
Elanco Animal Health 
A Division of Eli Lilly Australia Pty Ltd 
A.B.N. 000 233 992 
112 Wharf Road, West Ryde, N.S.W. 2114, Australia 
 
CONTACT NUMBERS: 
Tel: 
(02) 9878 7777 
Fax: 
(02) 9878 7720 
 
EMERGENCY TELEPHONE NUMBERS: 
Elanco Animal Health: 
1800 226 324 (Toll free) 
_OR _
Poisons Information Centre: 
131126 (Australia-wide) 
 
24 hour emergency contact number, CHEMWATCH 1800 039 008 ( spills
and accidents) 
 
SECTION 1 – IDENTIFICATION 
 
PRODUCT NAME: ElancoAH0359 Compudose-G Growth and Finishing Implants
for Steers 
amd Heifers 
Page 2 
 
OTHER NAMES: cattle implant; implant 
 
MANUFACTURER’S PRODUCT CODE: AH0359 
 
UN NUMBER: Not applicable 
 
DANGEROUS GOODS CLASS/SUBSIDIARY RISK: Not applicable 
 
HAZCHEM CODE: Not applicable 
 
POISONS SCHEDULE NUMBER: S5 
 
PACK SIZE AND CONTAINER TYPE: Box of 100 implants (5 foil pouch
envelopes x 20 
implants) 
 
USE: 
Major Recommended Uses: For improved growth promotion in pasture fed
steers and 
heifers. 
Major Recommended Method(s) of Application: Subcutaneous ear
implantation. 
 
SECTION 2 - COMPOSITION / INFORMATION ON INGREDIENTS 
 
INGREDIENT 
 
 
 
CAS   
CONCENTRATION % 
Trenbolone 
acetate 
  10161-34-9 
61.9 
Oestradiol 
   50-28-2 12.4 
Cholesterol 
  
                                
                                Read the complete document